Loading clinical trials...
Loading clinical trials...
A Phase 2 Randomized Study With a Non-randomized Cohort : Assessing Single-Fraction SBRT Versus Standard Palliative Radiation in Patients With Metastatic Disease (ASTEROID)
Conditions
Interventions
Palliative Radiation Therapy
Quality-of-Life Assessment
+2 more
Locations
3
United States
Roswell Park Cancer Institute
Buffalo, New York, United States
The Cancer Institute at St. Francis Hospital
East Hills, New York, United States
Good Samaritan Hospital
West Islip, New York, United States
Start Date
November 18, 2019
Primary Completion Date
November 18, 2027
Completion Date
November 18, 2027
Last Updated
April 25, 2025
NCT04988009
NCT05235165
NCT03270059
NCT05753306
NCT04870944
NCT04489719
Lead Sponsor
Roswell Park Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions